Results 191 to 200 of about 142,609 (269)

If you leave it, you lose it: Managing human–wildlife feeding interactions requires constant attention, interdisciplinary approaches and long‐term monitoring

open access: yesPeople and Nature, EarlyView.
Abstract Human–wildlife interactions are becoming more common as we progress through the Anthropocene. People tend to feed wildlife more regularly as it is often popularised by social media and can counteract their disconnect from the natural world. These interactions impact wildlife behaviour, feeding ecology and zoonotic transmission dynamics. Due to
Jane Faull   +9 more
wiley   +1 more source

Summer drought reduces total and litter-derived soil CO2 effluxes in temperate grassland – clues from a 13C litter addition experiment

open access: green, 2010
Michael W. Schmidt   +6 more
openalex   +1 more source

Hemophilia A: An Ideal Disease for Prenatal Therapy

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Hemophilia A (HA) is the most common inherited coagulation defect. Current state‐of‐the‐art treatment consists of frequent administration of prophylactic infusions of coagulation factor VIII (FVIII) protein or bispecific antibodies that replace the cofactor function of FVIIIa to maintain hemostasis. However, these treatments are far from ideal,
Christopher D. Porada   +2 more
wiley   +1 more source

Spatial variation of litter density and associated PAHs leakage on Aras River bank. [PDF]

open access: yesSci Rep
Yousefi M   +5 more
europepmc   +1 more source

Investigation of the Mechanism of Cinnamaldehyde in Irritable Bowel Syndrome Based via Network Pharmacology, Molecular Docking, and Animal Experiments

open access: yesPediatric Discovery, EarlyView.
Through network pharmacology and molecular docking, it has been discovered that CA can target MAOB, among other proteins, to exert a therapeutic effect in IBS. In vivo, CA lowered visceral hypersensitivity, anxiety and depression‐like behaviors, and fecal water content, highlighting its therapeutic potential for IBS via anti‐inflammatory pathways ...
Qingyang Yu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy